Erasca to Present at the 8th Annual Evercore Healthcare Conference

Core Insights - Erasca, Inc. is a clinical-stage precision oncology company focused on therapies for RAS/MAPK pathway-driven cancers [1][3] - The company will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025, including a fireside chat and one-on-one investor meetings [1] Company Overview - Erasca aims to "erase cancer" by discovering, developing, and commercializing therapies specifically targeting RAS/MAPK pathway-driven cancers [3] - The company was co-founded by pioneers in precision oncology and RAS targeting, emphasizing the development of novel therapies and combination regimens [3] - Erasca's scientific advisory board includes leading experts in the RAS/MAPK pathway, enhancing its capability to achieve its mission [3]